MedPath

Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals

Not Applicable
Active, not recruiting
Conditions
Omega 3 Index
Dry Eye Syndromes
Age-Related Macular Degeneration
Registration Number
NCT05763940
Lead Sponsor
Western University of Health Sciences
Brief Summary

The purpose of this study is to determine increases in the Omega Index test indicating optimal Omega-3s particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels for overall systemic benefits including healthy cardiovascular health and cholesterol levels as shown in the OmegaIndex (OmegaQuant) research.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
130
Inclusion Criteria
  • not currently taking Omega-3 supplements or fish oils
  • able to swallow softgel or chew gummies nutritional supplement daily for a 12 week period
  • able to make four (4) follow-up visits
Exclusion Criteria
  • allergy to fish or seafood
  • h/o Atrial fibrillation, or at risk of Afib
  • h/o congestive heart failure, heart disease, or prior myocardial infarction and/or cerebrovascular accident
  • noncompliance with study requirements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mean Changes in Omega-3 Index (OmegaQuant)Baseline, 4 weeks, 8 weeks, and 12 weeks

OmegaQuant provides Omega Index which is a percentage of omega 3 fatty acids particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the erythrocytes. The baseline values of OmegaIndex will be compared to repeated measurements obtained at at a 4-, 8- and 12-week. The OmegaQuant labs in Sioux Falls, SD analyze the blood samples to obtain omega-3 levels, omega-6 fatty acids, cis-Monounsaturated Fatty Acids, saturated fatty acids, trans fatty acids. Additionally, arachidonic acid to eicosapentaenoic acid ratio and omega 3 to omega 6 ratios will be calculated

Mean Changes in omega 3 to omega 6 ratiosBaseline, 4 weeks, 8 weeks, and 12 weeks

The baseline values of omega 3 to omega 6 ratios provided by the blood erythrocyte testing performed the OmegaQuant test will be compared to repeated measurements obtained at a 4-, 8- and 12-week.

Secondary Outcome Measures
NameTimeMethod
Mean changes to total cholesterol with Omega Boost supplementationBaseline, 4 weeks, 8 weeks, and 12 weeks

For the once-daily group, baseline total cholesterol is evaluated and will be repeated at various time points that is 4 weeks, 8 weeks, and 12 weeks. The groups will be compared. A reduction or decrease in values over time is considered an improvement.

Mean changes to low-density lipoprotein with Omega Boost supplementationBaseline, 4 weeks, 8 weeks, and 12 weeks

For the once-daily group, baseline low-density lipoprotein is evaluated and will be repeated at various time points which are 4 weeks, 8 weeks, and 12 weeks. The groups will be compared. A reduction or decrease in values over time is considered an improvement.

Mean Changes in General Health QuestionnaireBaseline, 4 weeks, 8 weeks, and 12 weeks

Eligible participants will be asked to complete the General Health Questionnaire during each visit to monitor secondary observational improvements and overall compliance. The questionnaire will assess: overall health \& wellbeing, overall mood, energy level, stress, mental focus, joint health; along with changes in skin, hair, nails, and dry eye (if applicable). With a lower score considered to be a worse outcome

Mean changes to Hb a1c with Omega Boost supplementationBaseline, 4 weeks, 8 weeks, and 12 weeks

For the once daily group Baseline Hba1c is evaluated and will be repeated at various time points that is 4, 8 and 12 weeks. The groups will be compared. A reduction or decrease in values over time is considered an improvement.

Mean changes to triglycerides with Omega Boost supplementationBaseline, 4 weeks, 8 weeks, and 12 weeks

For the once-daily group baseline triglycerides is evaluated and will be repeated at various time points which are 4 weeks, 8 week, and 12 weeks. The groups will be compared. A reduction or decrease in values over time is considered an improvement.

Mean changes to high-density lipoprotein with Omega Boost supplementationBaseline, 4 weeks, 8 weeks, and 12 weeks

For the once-daily group baseline high-density lipoprotein is evaluated and will be repeated at various time points that is 4 weeks, 8 weeks, and 12 weeks. The groups will be compared. An increase in values over time is considered an improvement.

Trial Locations

Locations (1)

Western University of Health Sciences

🇺🇸

Pomona, California, United States

Western University of Health Sciences
🇺🇸Pomona, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.